HIV-1, CM, gp120, Recombinant (Human Immunodeficiency Virus-1)
Catalog No : USB-209002
417.25€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | HIV-1, CM, gp120, Recombinant (Human Immunodeficiency Virus-1) | ||
|---|---|---|---|
| Catalog No | USB-209002 | ||
| Supplier’s Catalog No | 209002 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E. coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 100 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (10% PAGE, coomassie staining, RP-HPLC) | ||
| Form | Supplied as a lyophilized powder in 25mM Tris, 250mM glycine, 0.1% SDS. Reconstitute with 100ul sterile ddH2O for a ~1mg/ml stock. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (10% PAGE, coomassie staining, RP-HPLC) | ||
| Description | Human T-lymphotropic virus (HTLV) is a human, single-stranded RNA retrovirus that causes T-cell leukemia and T-cell lymphoma. The virus activates a subset of T-helper cells called Th1 cells. The result is a proliferation of Th1 cells and overproduction of Th1 related cytokines (mainly IFN-gamma and TNF-alpha). Feedback mechanisms of these cytokines cause a suppression of the Th2 lymphocytes and a reduction of Th2 cytokine production (mainly IL- 4, IL-5, IL-10 and IL-13). The end result is a reduction in the ability of the infected host to mount an adequate immune response to invading organisms that require a predominantly Th2 dependant response (these include parasitic infections and production of mucosal and humoral antibodies). Source: Recombinant protein corresponding to HIV-1, strain: BL21 DE3, expressed in E. coli. Molecular Weight: ~100kD Applications: Suitable for use as an antigen in ELISA and Western Blot. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved